SHCBP1高表达促进鼻咽癌细胞EMT过程
DOI:
作者:
作者单位:

1.贵州医科大学;2.贵州医科大学附属医院耳鼻咽喉科

作者简介:

通讯作者:

基金项目:

贵州省科学技术基金(黔科合基础-ZK[2021]一般424);贵州医科大学附属医院国家自然科学基金培育计划项目(gyfynsfc[2020]-7);贵州医科大学国家自然科学基金培育项目(20NSP023)


High expression of SHCBP1 promotes EMT in nasopharyngeal carcinoma cells
Author:
Affiliation:

1.Guizhou Medical University;2.Department of Otorhinolaryngology, Affiliated Hospital of Guizhou Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的:探究SHC SH2结构域结合蛋白1(SHCBP1)基因在鼻咽癌组织及鼻咽癌细胞系中的表达情况,及其对鼻咽癌细胞系的增殖、侵袭能力及上皮间质转化(EMT)(第一次出现请标记出中文全称?)过程的影响。方法:利用TCGA数据库分析SHCBP1在头颈鳞癌(HNSC)中的表达情况,并分析SHCBP1表达程度与肿瘤免疫细胞浸润程度的关系;收集2019年9月-2021年9月于贵州医科大学附属医院及贵州医科大学附属肿瘤医院经病理确诊的31例鼻咽癌初诊患者临床组织样本,所有患者就诊前均未接受任何放化疗,同时收集同期就诊的31例慢性鼻咽炎组织作为对照组。利用逆转录实时荧光定量PCR( RT-qPCR)检测临床样本及鼻咽癌细胞系5-8F中SHCBP1的表达情况。细胞实验以鼻咽癌细胞系5-8F、正常鼻咽部永生化上皮细胞系NP69作为研究对象。采用利用慢病毒载体shRNA-SHCBP1干扰技术沉默5-8F细胞中SHCBP1表达,并分为NC组(空病毒载体感染5-8F)、SHCBP1-shRNA组(沉默5-8F中SHCBP1表达)。CCK-8法、克隆形成实验检测SHCBP1对鼻咽癌细胞增殖的影响;划痕实验、Transwell迁移、侵袭实验检测SHCBP1对鼻咽癌细胞的转移、侵袭能力的影响。Western Blot检测NC组、SHCBP1-shRNA组中E-cadherin、N-cadherin、MMP9、Vimentin的表达情况。结果:在HNSC中SHCBP1高表达,表达量与Th2细胞浸润程度相关。与慢性鼻咽炎组织相比,鼻咽癌组织中SHCBP1明显高表达,差异具有统计学意义(P<0.05)。与NC组相比,SHCBP1-shRNA组鼻咽癌细胞增殖、迁移、侵袭能力均减弱,差异具有统计学意义(P<0.05)。SHCBP1-shRNA组E-cadherin表达较NC组升高,N-cadherin、MMP9、Vimentin表达较NC组降低,差异具有统计学意义(P<0.05)。结论:SHCBP1在鼻咽癌中高表达,并可促进鼻咽癌细胞增殖、侵袭、迁移及激活EMT过程。

    Abstract:

    Objective: To investigate the expression of SHCBP1 gene in nasopharyngeal carcinoma tissues and nasopharyngeal carcinoma cell lines, and its effect on the proliferation, invasion ability and EMT process of nasopharyngeal carcinoma cell lines. Methods: The expression of SHCBP1 in head and neck squamous cell carcinoma (HNSC) was analyzed by TCGA database, and the relationship between the expression of SHCBP1 and the degree of tumor immune cell infiltration was analyzed. The clinical tissue samples of 31 patients with nasopharyngeal carcinoma diagnosed by pathology in the affiliated Hospital of Guizhou Medical University and the affiliated Cancer Hospital of Guizhou Medical University from September 2019 to September 2021 were collected. At the same time, 31 cases of chronic nasopharyngitis were collected as the control group. The expression of SHCBP1 in clinical samples and nasopharyngeal carcinoma cell line 5-8F was detected by reverse transcriptase real-time fluorescence quantitative PCR (RT-qPCR). In the cell experiment, nasopharyngeal carcinoma cell line 5-8F and normal nasopharyngeal immortalized epithelial cell line NP69 were used as the subjects. SHCBP1 expression in 5-8F cells was silenced by lentiviral vector shRNA-SHCBP1 interference technique and divided into NC group (empty viral vector infected with 5-8F) and SHCBP1-shRNA group (silencing SHCBP1 expression in 5-8F cells). The effect of SHCBP1 on the proliferation of nasopharyngeal carcinoma cells was detected by CCK-8 assay and clone formation assay, and the effect of SHCBP1 on the metastasis and invasion of nasopharyngeal carcinoma cells was detected by scratch test, Transwell migration and invasion test. Western Blot was used to detect the expression of E-cadherin, N-cadherin, MMP9 and Vimentin in NC group and SHCBP1-shRNA group. Results: SHCBP1 was highly expressed in HNSC, and the expression was related to the degree of Th2 cell infiltration. Compared with chronic nasopharyngitis, the expression of SHCBP1 in nasopharyngeal carcinoma was significantly higher (P<0.05). The proliferation, migration and invasion of nasopharyngeal carcinoma cells in SHCBP1-shRNA group were significantly lower than those in NC group (P< 0.05). The expression of E-cadherin in SHCBP1-shRNA group was higher than that in NC group, while the expression of N-cadherin, MMP9 and Vimentin was lower than that in NC group.Conclusion: SHCBP1 is highly expressed in nasopharyngeal carcinoma and can promote the proliferation, invasion, migration and activation of EMT in nasopharyngeal carcinoma cells.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2022-03-18
  • 最后修改日期:2022-05-04
  • 录用日期:2022-05-06
  • 在线发布日期:
新投稿系统运行通知

作者投稿请直接点击左侧“作者登录”,请不要进入旧版入口。如登录或投稿中遇到任何问题,请联系电话13311390237。谢谢!

关闭